WallStreetZenWallStreetZen

NASDAQ: HUMA
Humacyte Inc Stock Ownership - Who owns Humacyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Humacyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brady W. DouganDirector2025-08-20591,685$1.58
$934.86kSell
Laura E. NiklasonPresident CEO and Director2025-08-20591,685$1.58
$934.86kSell
Brady W. DouganDirector2025-08-191,100,000$1.63
$1.79MSell
Laura E. NiklasonPresident CEO and Director2025-08-191,100,000$1.63
$1.79MSell
Brady W. DouganDirector2025-08-18549,360$1.83
$1.01MSell
Laura E. NiklasonPresident CEO and Director2025-08-18549,360$1.83
$1.01MSell
William John ScheesseleChief Commercial Officer2025-04-146,493$1.54
$10.00kBuy
Shamik J. ParikhChief Medical Officer2025-04-107,500$1.55
$11.63kBuy
Dale A. SanderCFO and Chief Corp. Deve. Off.2025-04-1020,000$1.53
$30.60kBuy
Kathleen SebeliusDirector2025-04-0850,000$1.32
$66.00kBuy

1 of 2

HUMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HUMA insiders and whales buy or sell their stock.

HUMA Shareholders

What type of owners hold Humacyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fresenius Medical Care Holdings Inc9.78%18,312,735$18.86MInsider
Blackrock Inc5.29%9,901,795$10.20MInstitution
Ayabudge LLC4.37%8,191,140$8.44MInsider
Vanguard Group Inc4.02%7,520,055$7.75MInstitution
Geode Capital Management LLC1.65%3,096,216$3.19MInstitution
State Street Corp1.29%2,408,043$2.48MInstitution
Morgan Stanley1.12%2,096,753$2.16MInstitution
Ubs Group Ag1.07%2,002,335$2.06MInstitution
Woodline Partners LP1.07%2,002,073$2.06MInstitution
Brady W. Dougan0.74%1,392,091$1.43MInsider

1 of 3

HUMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HUMA24.49%16.42%Net Selling
CAMP52.04%47.96%Net Buying
IRD5.79%94.21%Net SellingNet Selling
SRZN24.20%75.80%Net BuyingNet Buying
RNAC12.77%87.23%Net BuyingNet Buying
View Top Biotech Stocks

Humacyte Stock Ownership FAQ

Who owns Humacyte?

Humacyte (NASDAQ: HUMA) is owned by 24.49% institutional shareholders, 16.42% Humacyte insiders, and 59.08% retail investors. Fresenius Medical Care Holdings Inc is the largest individual Humacyte shareholder, owning 18.31M shares representing 9.78% of the company. Fresenius Medical Care Holdings Inc's Humacyte shares are currently valued at $18.31M.

If you're new to stock investing, here's how to buy Humacyte stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.